Search

David L Peritt

from Cambridge, MA
Age ~60
Get Report
Also known as:
David P Peritt, Dave Peritt
Phone and address:
110 2Nd St PH 12, Cambridge, MA 02141
Related to:
Jonathan M Peritt, 58Jonathan M Rini, 40Mary Rini, 63Shirley A Rini
Connected to:
Jonathan Peritt, 56Cheryll D Peritz, 59Tiina M Peritz, 51Dionise Periu, 66Osmany S Periu, 63Chris Perivoliotis, 80Isaac Periyasamy, 51Rajendran Periyaswamy, 56James R Perizzolo, 68Alexandra Perjes, 43

David Peritt Phones & Addresses

  • 110 2Nd St PH 12, Cambridge, MA 02141
  • 9044 Keeler Ave, Skokie, IL 60076 (847) 972-1576
  • 4126 Suffield Ct, Skokie, IL 60076 (847) 972-1576
  • Exton, PA
  • Philadelphia, PA
  • 407 Conshohocken State Rd, Bala Cynwyd, PA 19004 (610) 664-5955
  • Beltsville, MD
  • New York, NY
  • 9044 Keeler Ave, Skokie, IL 60076 (610) 664-5955

Work

Company: Hospira Nov 2011 Address: Lake Forest, IL USA Position: Scientific director, immunology

Education

Degree: Ph.D. School / High School: University of Pennsylvania 1992 to 1998 Specialities: Immunology

Skills

Immunology • Biotechnology • Cell • Antibodies • R&D • Medical Devices • Biopharmaceuticals • Life Sciences • Cell Biology • Oncology • Lifesciences • Pharmaceutical Industry • Monoclonal Antibodies • Cancer • Molecular Biology • Regenerative Medicine • In Vitro • Technology Transfer • Due Diligence • Research and Development • Clinical Development • Drug Discovery • Cell Based Assays • Hebrew • Public Speaking • Drug Development

Interests

Science and Technology • Education • Health

Industries

Biotechnology

Resumes

Resumes

David Peritt Photo 1

Chief Technology Officer At Sigilon, A Biotechnology Company Looking To Transform How We Deliver Biologics To

View page
Location:
110 2Nd St, Cambridge, MA 02141
Industry:
Biotechnology
Work:
Hospira - Lake Forest, IL USA since Nov 2011
Scientific Director, Immunology
Hospira - Greater Chicago Area Jul 2008 - Nov 2011
Scientific Director Cell Therapy and Regenerative Medicine
Therakos Research (Johnson & Johnson) 2005 - 2008
Director
Therakos, Inc. - A Johnson & Johnson Company 2005 - Sep 2007
Director of Research
Therakos Research (Johnson 2001 - 2005
Associate director
Education:
University of Pennsylvania 1992 - 1998
Ph.D., Immunology The Hebrew University 1988 - 1991
MSc, Immunology University of Maryland College Park 1982 - 1986
B.Sc., Science High Point High School 1979 - 1982
HS diploma, General
Skills:
Immunology
Biotechnology
Cell
Antibodies
R&D
Medical Devices
Biopharmaceuticals
Life Sciences
Cell Biology
Oncology
Lifesciences
Pharmaceutical Industry
Monoclonal Antibodies
Cancer
Molecular Biology
Regenerative Medicine
In Vitro
Technology Transfer
Due Diligence
Research and Development
Clinical Development
Drug Discovery
Cell Based Assays
Hebrew
Public Speaking
Drug Development
Interests:
Science and Technology
Education
Health

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Peritt
Treasurer
University City Eruv Corporation
Membership Organization · Nonclassifiable Establishments
111 S 15 St, Philadelphia, PA 19102

Publications

Us Patents

Nucleic Acids Encoding Il-12 Antibody

View page
US Patent:
7063964, Jun 20, 2006
Filed:
Oct 28, 2004
Appl. No.:
10/975740
Inventors:
David M. Knight - Berwyn PA, US
David Peritt - Bala Cynwyd PA, US
Bernard Scallon - Collegeville PA, US
David Shealy - Downingtown PA, US
International Classification:
C12N 5/10
C12N 15/13
C12N 15/63
US Classification:
435 691, 435365, 435325, 435367, 4353721, 4352523, 4353201
Abstract:
The present invention relates to an anti-IL-12 antibody, including isolated nucleic acids that encode an anti-IL-12 antibody, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Anti-Il-12 Antibodies And Compositions

View page
US Patent:
7166285, Jan 23, 2007
Filed:
Oct 28, 2004
Appl. No.:
10/975708
Inventors:
David M. Knight - Berwyn PA, US
David Peritt - Bala Cynwyd PA, US
Bernard Scallon - Collegeville PA, US
David Shealy - Downingtown PA, US
Assignee:
Centocor, Inc. - Malvern PA
International Classification:
C07K 16/24
A61K 39/395
US Classification:
4241451, 4241301, 4241391, 5303871, 5303879, 53038823, 5303892
Abstract:
The present invention relates to an anti-IL-12 antibody, including isolated nucleic acids that encode an anti-IL-12 antibody, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Method For Treating Psoriasis By Administering An Anti-Il-12 Antibody

View page
US Patent:
7279157, Oct 9, 2007
Filed:
Oct 28, 2004
Appl. No.:
10/975883
Inventors:
David M. Knight - Berwyn PA, US
David Peritt - Bala Cynwyd PA, US
Bernard Scallon - Collegeville PA, US
David Shealy - Downingtown PA, US
Assignee:
Centocor, Inc. - Malvern PA
International Classification:
A61K 39/395
US Classification:
4241301, 4241391, 4241411, 4241451
Abstract:
The present invention relates to an anti-IL-12 antibody, including isolated nucleic acids that encode an anti-IL-12 antibody, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Anti-Il-6 Antibodies, Compositions, Methods And Uses

View page
US Patent:
7291721, Nov 6, 2007
Filed:
Oct 26, 2002
Appl. No.:
10/280716
Inventors:
David Knight - Berwyn PA, US
David Peritt - Bala Cynwyd PA, US
Mohit Trikha - Paoli PA, US
Assignee:
Centocor, Inc. - Malvern PA
International Classification:
C07H 21/04
US Classification:
536 2353, 4353201, 435 696
Abstract:
The present invention relates to at least one novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies derived from the murine CLB-8 antibody, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Nucleic Acids Encoding Anti-Il-12 Antibodies, And Methods Of Production

View page
US Patent:
7560247, Jul 14, 2009
Filed:
Jan 29, 2007
Appl. No.:
11/668256
Inventors:
David M. Knight - Berwyn PA, US
David Peritt - Bala Cynwyd PA, US
Bernard Scallon - Collegeville PA, US
David Shealy - Downingtown PA, US
Assignee:
Centocor Ortho Biotech Inc. - Malvern PA
International Classification:
C12N 5/10
C12N 15/13
C12N 15/62
C12N 15/63
US Classification:
435 691, 435325, 4352523, 4353201, 536 2353
Abstract:
Isolated nucleic acids encoding an anti-IL-12 antibody or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders.

Anti-Il-6 Antibodies, Compositions, Methods And Uses

View page
US Patent:
7612182, Nov 3, 2009
Filed:
Aug 1, 2007
Appl. No.:
11/832323
Inventors:
David Knight - Berwyn PA, US
David Peritt - Bala Cynwyd PA, US
Mohit Trikha - Paoli PA, US
Assignee:
Centocor, Inc. - Malvern PA
International Classification:
C07K 16/00
US Classification:
5303881, 53038823
Abstract:
The present invention relates to at least one novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies derived from the murine CLB-8 antibody, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Anti-Il-6 Antibodies, Compositions, Methods And Uses

View page
US Patent:
7833786, Nov 16, 2010
Filed:
Oct 30, 2007
Appl. No.:
11/927925
Inventors:
David Knight - Berwyn PA, US
David Peritt - Bala Cynwyd PA, US
Mohit Trikha - Paoli PA, US
Assignee:
Centocor, Inc. - Malvern PA
International Classification:
C12N 5/12
US Classification:
435326, 536 231
Abstract:
The present invention relates to at least one novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies derived from the murine CLB-8 antibody, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Anti-Il-12 Antibodies And Compositions

View page
US Patent:
7887807, Feb 15, 2011
Filed:
Jul 9, 2009
Appl. No.:
12/500120
Inventors:
David M. Knight - Berwyn PA, US
David Peritt - Bala Cynwyd PA, US
Bernard Scallon - Collegeville PA, US
David Shealy - Downingtown PA, US
Assignee:
Centocor Ortho Biotech Inc. - Horsham PA
International Classification:
C07K 16/24
A61K 39/395
US Classification:
4241451, 5303873, 5303881, 53038815, 53038823
Abstract:
Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders.
Control profile
David L Peritt from Cambridge, MA, age ~60 Get Report